{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-001246","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.627007+00:00","generated_at":"2026-05-28T03:04:51.712547+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ardelyx reports preliminary Q4 2024 net product sales: IBSRELA $54M, XPHOZAH $57M","bullets":["IBSRELA net product sales: ~$54M in Q4 2024, ~$158M full year.","XPHOZAH net product sales: ~$57M in Q4 2024, ~$161M full year.","Cash, cash equivalents, and short-term investments: ~$250M as of Dec 31, 2024 (unaudited)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-001246","json":"https://secwatch.observer/filing/0001628280-25-001246.json","markdown":"https://secwatch.observer/filing/0001628280-25-001246.md","text":"https://secwatch.observer/filing/0001628280-25-001246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025001246/0001628280-25-001246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000162828025001246/ardx-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:04:51.712547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}